About the Company
We do not have any company description for Acutus Medical, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
210
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Acutus Medical, Inc.
Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript
SA Transcripts 152.28KFollowers Follow Acutus Medical, Inc. (OTCPK:AFIB) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Caroline Corner - IR David Roman - CEO ...
Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Call Transcript
Acutus Medical, Inc. misses on earnings expectations. Reported EPS is $-0.63 EPS, expectations were $0.61. Operator: Good day, and thank you for standing by, and welcome to the Acutus Medical ...
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass ... - Nasdaq
Acutus Medical, Inc., which belongs to the Zacks Medical - Drugs industry, posted revenues of $4.96 million for the quarter ended December 2022, surpassing the Zacks Consensus Estimate by 3.38%.
Acutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call Transcript
Acutus Medical, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.69. Operator: Good afternoon and thank you for standing by. Welcome to the Acutus Medical First ...
Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2022 Results ...
Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2022 Results - Earnings Call Transcript l: ZIP May 12, 2022 10:43 PM ET Acutus Medical, Inc. (AFIB) Stock AFIB SA Transcripts 154.89K Follower s ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Acutus Medical, Inc ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the ...
Acutus Medical, Inc. (AFIB) Reports Q4 Loss, Tops Revenue Estimates
Acutus Medical, Inc., which belongs to the Zacks Medical - Drugs industry, posted revenues of $4.36 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 1.44%.
AFIB NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Acutus Medical ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021 and November 11, 2021, inclusive (the ...
Similar Companies
Loading the latest forecasts...